glp-1 weight loss news

Weight loss drug is not taking easy way out

Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.

UPI News on MSN · 4d

Massive study looks at benefits, risks of GLP-1 weight-loss drugs

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.

The Washington Post on MSN · 6d

Sweeping review suggests weight-loss drugs’ effect on 175 conditions

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.

6don MSN

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Hosted on MSN23h

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Futurism on MSN4h

Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

TAG24 NEWS on MSN6m

Major study of weight-loss jabs shows slew of benefits but also risks

Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...

Demand for loose skin surgery rises with GLP-1 weight loss meds

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

2don MSN

Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results